Top News
Trending Stories
Yoda Diagnostics hosts ‘Yoda Early Mind Summit’ in New Delhi
Driving focus on early autism detection and clinical insights
Bayer to offer Eylea 2mg to treat retinal diseases at lower...
Eylea 2mg is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
Cardiology experts emphasize early diagnosis amid rising incidence of Bradycardia
Experts also emphasized that advanced age remains the strongest risk factor for bradycardia, with nearly 75–80% of pacemaker implants occurring in individuals above 65 years
Agriculture
Agrivartan FPO from Indapur exports bananas to Dubai
Shipment facilitated by Palladium Consulting India Pvt. Ltd. in partnership with Pure Planet India Pvt. Ltd.
Education
Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first...
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Reader’s Choice
Face to Face
“Research must be designed for translation, not just for publications”: Dr...
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Chat with BioVoice
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans
